Stay updated on Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedThe page revision label has been incremented from v3.5.2 to v3.5.3, indicating a minor technical update without changing the displayed study details.SummaryDifference0.0%

- Check11 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedAn addition: Revision: v3.5.0. A deletion: Revision: v3.4.3.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check75 days agoChange DetectedAdministrative updates: v3.4.2 was added; a government funding lapse notice (and the v3.4.1 revision notice) was removed. These changes do not affect study content or user actions on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedAdded a site-wide notice about government funding and NIH Clinical Center status, with links to cc.nih.gov and opm.gov. Updated the page revision tag from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Drug MOR106 in Atopic Dermatitis Clinical Trial page.